Manager, Nursing Operations

Illinois, United States

Apply with AI Apply

$100,000 – $125,000Compensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Research, Clinical TrialsIndustries

Requirements

Candidates must hold a graduate degree from an accredited nursing program, with a Bachelor of Science in Nursing (BSN) preferred. They should possess at least three years of relevant work experience, specifically working with oncology patients in clinical research, and demonstrate excellent interpersonal, written, and verbal communication skills. Proficiency in Google Suite applications such as Gmail, Google Docs, and Google Sheets is required, along with a keen attention to detail and the ability to work efficiently under time constraints.

Responsibilities

The Manager, Nursing Operations will read and understand clinical trial protocols to identify patient matches for various cancer types, collaborate with multiple data sources to extract relevant information, evaluate patients against inclusion/exclusion criteria, develop enrollment strategies with Site Operations and Pharma Operations, manage high-priority client relationships, oversee a team of clinical research nurse navigators, report on team performance, and manage workloads and priorities across the TIME Network.

Skills

Oncology

Clinical Research

EMR

Patient Matching

Genetic and Clinical Criteria

Team Management

Google Suite

Attention to Detail

Agile Methodology

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free